Stay updated with breaking news from 80067710. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) have been assigned an average recommendation of “Hold” from the seven analysts that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and three have issued a buy recommendation on the […]
StockNews.com started coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a report published on Wednesday. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other research firms have also commented on SGMO. HC Wainwright reduced their price target on shares of Sangamo Therapeutics from $5.00 to $3.00 and set […]
StockNews.com assumed coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research note issued to investors on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. SGMO has been the topic of a number of other research reports. Royal Bank of Canada reissued a sector perform rating and […]
StockNews.com assumed coverage on shares of Sangamo Therapeutics (NASDAQ:SGMO – Free Report) in a research report released on Monday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Several other research analysts have also recently weighed in on SGMO. Wells Fargo & Company reissued an equal weight rating and issued a $1.00 […]
Mirae Asset Global Investments Co. Ltd. increased its position in shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Free Report) by 16.8% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 613,724 shares of the biopharmaceutical company’s stock after acquiring an additional 88,444 shares during […]